maximizing Oncology analysis with built-in KRAS Assay products and services and RAS Assays
inside the quickly evolving subject of oncology investigate, exact and efficient mutation screening is crucial for acquiring qualified therapies. The KRAS solutions Platform plays a pivotal position With this landscape by featuring complete methods for KRAS mutation profiling and analysis. KRAS mutations, present in roughly ninety five% of RAS-link